Adjunctive use of an artificial intelligence (AI) software demonstrated nearly equivalent sensitivity and over 28 percent higher accuracy in comparison to radiologist assessment of breast ultrasound images for breast lesions, according to new research presented at the recent Society of Breast Imaging (SBI) conference.
In new research comparing the use of adjunctive artificial intelligence (AI) to radiologist assessment of breast ultrasound images, researchers found that adjunctive AI had over a 28 percent higher accuracy rate and a nearly 40 percent higher specificity rate for diagnosing breast lesions.
For the retrospective study, presented at the recent Society of Breast Imaging (SBI) conference, researchers assessed the adjunctive use of Koios Decision Support (DS) Breast (Koios Medical) in interpreting breast ultrasound for the diagnosis of breast lesions. The study involved 154 biopsy-proven cases (mean age of 53.2) from a diverse patient population comprised of 33.1 percent White patients, 29.9 percent Hispanic patients, 15.6 percent Black/African American patients, 14 percent Asian patients and 12.3 percent multi-racial patients, according to the study.
The researchers found that use of the Koios DS Breast software had a 60.4 accuracy rate in comparison to a 31.8 percent accuracy rate for radiologist assessment of breast lesions on ultrasound as well as a 97.5 sensitivity rate. There was also a significant reduction of false positives with the AI software (60) in comparison to 105 false positive diagnoses for radiologist assessment without AI.
Images courtesy of the Society of Breast Imaging (SBI).
“Our preliminary results show there is promise that an AI (decision support) system would be an accurate and reliable second opinion in diagnostic ultrasound examinations,” noted lead study author Clara Koo, M.D., a diagnostic radiology resident affiliated with the Mount Sinai Health System in New York, N.Y., and colleagues. “Furthermore, (the AI software) has the potential to reduce false positive readings, especially in younger patients, reducing the burden of unnecessary biopsies.”
In the diverse patient cohort, the researchers also noted no evidence of racial- or machine-based bias affecting the study results. Koo and colleagues added that there was increasing correlation between the AI software and radiologist assessment with advancing patient age.
(Editor’s note: For related content, see “Automated Breast Ultrasound: Is it a Viable Second-Look Option for Women with Dense Breasts?” and “Can Multimodal AI Improve Cancer Detection in Dense Breasts?”)
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.